Especially, PPIs have been studied to target TNF‐α monoclonal antibodies, anti‐sensory targeting Smad7, and non‐steroidal anti‐inflammatory drugs to prevent cancer based on inflammation (Figure 3).253. Here, TNF is linked to cancer.